Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Acepodia, Alterity, Basilea, Beigene, Biomarin, Daewoong, Daiichi Sankyo, Eli Lilly, Eyepoint, Hoth, Innovent, Kyowa Kirin, Moderna, Novavax, Ocumension, Valneva.